Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis

Mechanisms of Subcutaneous Immunotherapy In patients with allergic rhinitis, successful subcutaneous immunotherapy may involve blunting of the seasonal in- crease in serum

AIT: allergen immunotherapy; AR: allergic rhinitis; ARIA: allergic rhinitis and its impact on asthma; BMI: body mass index; CRF: case report form; DSM: diagnostic and

evaluated 143 mothers with allergic rhinitis, some of which received AIT (unspecified whether SCIT or SLIT) during or prior to pregnancy, for the development of any allergic

My study has revealed subcutaneous immunotherapy for patients with allergic rhinitis with or without polyposis reduces nasal and non nasal symptoms significantly. There is

Health Economic Analysis of Allergen Immunotherapy (AIT) for the Management of Allergic Rhinitis, Asthma, Food Allergy and Venom Allergy: A Systematic Overview.. 1 Miqdad Asaria,

Figure 3 Poisson regression analysis of the mean number of allergic rhinitis (AR) medications during the follow-up period for SCIT and SLIT grass and tree products compared with

Most patients seeking treatment for allergic rhinitis are polysensitized, and allergen immunotherapy has proven efficacy in large, robust clinical trials in these

To determine the comparative clinical effectiveness and cost-effectiveness of SCIT and SLIT for seasonal allergic rhinitis (SAR) by (1) undertaking a systematic review of